These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 32372482

  • 1. Targeted RNA sequencing with touch imprint cytology samples for non-small cell lung cancer patients.
    Seto K, Masago K, Fujita S, Haneda M, Horio Y, Hida T, Kuroda H, Hosoda W, Okubo KI.
    Thorac Cancer; 2020 Jul; 11(7):1827-1834. PubMed ID: 32372482
    [Abstract] [Full Text] [Related]

  • 2. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
    Tan AC, Lai GGY, Tan GS, Poon SY, Doble B, Lim TH, Aung ZW, Takano A, Tan WL, Ang MK, Tan BS, Devanand A, Too CW, Gogna A, Ong BH, Koh TPT, Kanesvaran R, Ng QS, Jain A, Rajasekaran T, Lim AST, Lim WT, Toh CK, Tan EH, Lim TKH, Tan DSW.
    Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
    [Abstract] [Full Text] [Related]

  • 3. Cytology smears as excellent starting material for next-generation sequencing-based molecular testing of patients with adenocarcinoma of the lung.
    Velizheva NP, Rechsteiner MP, Wong CE, Zhong Q, Rössle M, Bode B, Moch H, Soltermann A, Wild PJ, Tischler V.
    Cancer Cytopathol; 2017 Jan; 125(1):30-40. PubMed ID: 27636102
    [Abstract] [Full Text] [Related]

  • 4. Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers.
    Ramani NS, Chen H, Broaddus RR, Lazar AJ, Luthra R, Medeiros LJ, Patel KP, Rashid A, Routbort MJ, Stewart J, Tang Z, Bassett R, Manekia J, Barkoh BA, Dang H, Roy-Chowdhuri S.
    Cancer Cytopathol; 2021 May; 129(5):374-382. PubMed ID: 33119213
    [Abstract] [Full Text] [Related]

  • 5. Optimization of Routine Testing for MET Exon 14 Splice Site Mutations in NSCLC Patients.
    Descarpentries C, Leprêtre F, Escande F, Kherrouche Z, Figeac M, Sebda S, Baldacci S, Grégoire V, Jamme P, Copin MC, Tulasne D, Cortot AB.
    J Thorac Oncol; 2018 Dec; 13(12):1873-1883. PubMed ID: 30195702
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic Utility of Gene Fusion Panel to Detect Gene Fusions in Fresh and Formalin-Fixed, Paraffin-Embedded Cancer Specimens.
    Haley L, Parimi V, Jiang L, Pallavajjala A, Hardy M, Yonescu R, Morsberger L, Stinnett V, Long P, Zou YS, Gocke CD.
    J Mol Diagn; 2021 Oct; 23(10):1343-1358. PubMed ID: 34358677
    [Abstract] [Full Text] [Related]

  • 7. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
    Giardina T, Robinson C, Grieu-Iacopetta F, Millward M, Iacopetta B, Spagnolo D, Amanuel B.
    Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
    [Abstract] [Full Text] [Related]

  • 8. Next-generation sequencing informs diagnosis and identifies unexpected therapeutic targets in lung squamous cell carcinomas.
    Sands JM, Nguyen T, Shivdasani P, Sacher AG, Cheng ML, Alden RS, Jänne PA, Kuo FC, Oxnard GR, Sholl LM.
    Lung Cancer; 2020 Feb; 140():35-41. PubMed ID: 31855703
    [Abstract] [Full Text] [Related]

  • 9. Suitability of frozen cell pellets from cytology specimens for the Amoy 9-in-1 assay in patients with non-small cell lung cancer.
    Kodama H, Murakami H, Mamesaya N, Kobayashi H, Omori S, Wakuda K, Ko R, Ono A, Kenmotsu H, Naito T, Matsumoto S, Goto K, Shimizu T, Gon Y, Takahashi T.
    Thorac Cancer; 2024 Jul; 15(21):1665-1672. PubMed ID: 38898747
    [Abstract] [Full Text] [Related]

  • 10. Next-Generation Sequencing for Genotyping of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples in Lung Cancer.
    Xie F, Zheng X, Mao X, Zhao R, Ye J, Zhang Y, Sun J.
    Ann Thorac Surg; 2019 Jul; 108(1):219-226. PubMed ID: 30885850
    [Abstract] [Full Text] [Related]

  • 11. Clinical next-generation sequencing in patients with non-small cell lung cancer.
    Hagemann IS, Devarakonda S, Lockwood CM, Spencer DH, Guebert K, Bredemeyer AJ, Al-Kateb H, Nguyen TT, Duncavage EJ, Cottrell CE, Kulkarni S, Nagarajan R, Seibert K, Baggstrom M, Waqar SN, Pfeifer JD, Morgensztern D, Govindan R.
    Cancer; 2015 Feb 15; 121(4):631-9. PubMed ID: 25345567
    [Abstract] [Full Text] [Related]

  • 12. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
    Nicholson AG, Gonzalez D, Shah P, Pynegar MJ, Deshmukh M, Rice A, Popat S.
    J Thorac Oncol; 2010 Apr 15; 5(4):436-41. PubMed ID: 20068475
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC).
    Liao J, Shen J, Leng Q, Qin M, Zhan M, Jiang F.
    Thorac Cancer; 2020 Mar 15; 11(3):762-768. PubMed ID: 31994346
    [Abstract] [Full Text] [Related]

  • 14. Molecular analysis of peripheral lung adenocarcinoma in brush cytology obtained by EBUS plus fluoroscopy-guided bronchoscopy.
    Sánchez-Font A, Chalela R, Martín-Ontiyuelo C, Albero-González R, Dalmases A, Longarón R, Alonso-Espinaco V, Curull V, Bellosillo B, Pijuan L.
    Cancer Cytopathol; 2018 Oct 15; 126(10):860-871. PubMed ID: 30291816
    [Abstract] [Full Text] [Related]

  • 15. Detection of multiple types of cancer driver mutations using targeted RNA sequencing in non-small cell lung cancer.
    Ju S, Cui Z, Hong Y, Wang X, Mu W, Xie Z, Zeng X, Su L, Lin X, Zhang Z, Zhang Q, Song X, You S, Chen R, Chen W, Xu C, Zhao J.
    Cancer; 2023 Aug 01; 129(15):2422-2430. PubMed ID: 37096747
    [Abstract] [Full Text] [Related]

  • 16. Tumor mutational burden on cytological samples: A pilot study.
    Pepe F, Pisapia P, Gristina V, Rocco D, Micheli M, Micheli P, Iaccarino A, Tufano R, Gragnano G, Russo G, De Luca C, Sgariglia R, Nacchio M, Girolami I, Eccher A, Russo A, Troncone G, Malapelle U.
    Cancer Cytopathol; 2021 Jun 01; 129(6):460-467. PubMed ID: 33378102
    [Abstract] [Full Text] [Related]

  • 17. Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.
    Hamblin A, Wordsworth S, Fermont JM, Page S, Kaur K, Camps C, Kaisaki P, Gupta A, Talbot D, Middleton M, Henderson S, Cutts A, Vavoulis DV, Housby N, Tomlinson I, Taylor JC, Schuh A.
    PLoS Med; 2017 Feb 01; 14(2):e1002230. PubMed ID: 28196074
    [Abstract] [Full Text] [Related]

  • 18. Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.
    Kanaji N, Bandoh S, Ishii T, Tadokoro A, Watanabe N, Takahama T, Haba R, Imataki O, Dobashi H, Matsunaga T.
    Lung Cancer; 2012 Aug 01; 77(2):293-8. PubMed ID: 22494566
    [Abstract] [Full Text] [Related]

  • 19. Combined targeted DNA and RNA sequencing of advanced NSCLC in routine molecular diagnostics: Analysis of the first 3,000 Heidelberg cases.
    Volckmar AL, Leichsenring J, Kirchner M, Christopoulos P, Neumann O, Budczies J, Morais de Oliveira CM, Rempel E, Buchhalter I, Brandt R, Allgäuer M, Talla SB, von Winterfeld M, Herpel E, Goeppert B, Lier A, Winter H, Brummer T, Fröhling S, Faehling M, Fischer JR, Heußel CP, Herth F, Lasitschka F, Schirmacher P, Thomas M, Endris V, Penzel R, Stenzinger A.
    Int J Cancer; 2019 Aug 01; 145(3):649-661. PubMed ID: 30653256
    [Abstract] [Full Text] [Related]

  • 20. Comparison of targeted next-generation sequencing with conventional sequencing for predicting the responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy in never-smokers with lung adenocarcinoma.
    Han JY, Kim SH, Lee YS, Lee SY, Hwang JA, Kim JY, Yoon SJ, Lee GK.
    Lung Cancer; 2014 Aug 01; 85(2):161-7. PubMed ID: 24857785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.